Catalyst Wire Dossier Catalyst Wire Dossier

Oxybutynin chloride extended-release

Oxybutynin chloride · Rising Pharma Holdings, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Oxybutynin chloride extended-release, covering 2016-05-27 to 2023-05-24. Get the full timeline:

Most recent: FDA Approved: OXYBUTYNIN CHLORIDE EXTENDED RELEASE — Supplemental Application (Rising Pharma Holdings, Inc.)

See pricing